MIT CLASS PROJECT TURNS INTO AN FDA-CLEARED TREATMENT FOR TREMORS

Summary from the TLDR Founders newsletter

Encora's tremor wristband had people asking to buy it after a student demonstration, but it was nine years from that demonstration to FDA clearance. The MIT team chose the idea by a 16-to-one vote. Its proposer was the only dissenter. After initially working on Parkinson's, the company shifted to essential tremor, citing more patients and less drug-development activity. Its clearance covers adults with essential tremor. If your prototype attracts buyers, which patient group can you actually seek clearance to serve, and how long can you fund the trials needed to reach them?